Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
4,803 total articles
HCI Group (HCI) looks attractively valued on several fundamental metrics — EV/EBITDA ~3.8, free cash flow of $404M, and return on equity near 24% — with a $2.1B market cap and a corporate catalyst in the near term. Technicals are cautionary, but for investors willing to accept momentum risk, a structured buy with a disciplined stop offers a favorab…
PepsiCo (PEP) mixes low volatility with a reliable dividend, wide moat snack/beverage brands, and heavy liquidity. At $160.15, the stock trades near its 50-day average and offers a 3.5% dividend yield; that combination makes short-term option selling a compelling income strategy. This idea outlines a mid-term (45 trading days) covered-call plan (wi…
Lam Research has beaten recent estimates, guided higher, and sits squarely in the AI-driven capital expenditure cycle. Balance-sheet strength, robust free cash flow, and visible demand from memory and logic customers support a constructive long trade. Valuation is rich but not without justification given margins and cash generation; manage position…
Trupanion (TRUP) looks buyable after recent weakness. The stock trades near its 52-week low, valuation is reasonable relative to free cash flow, and recent industry recognition plus improving fundamentals create a clear risk-reward for a mid-term swing trade.
Progressive ($PGR) is experiencing a pause in top-line momentum, but underlying profitability and free cash generation remain robust. At ~$201, the stock trades near its 52-week low on an attractive ~11x earnings multiple and an EV/EBITDA around 9.1. This trade idea lays out a mid-term long with a clear entry, stop and target, while acknowledging c…
PepsiCo (PEP) has popped into early 2026 but still trades at a sensible multiple given its cash generation and dividend history. With a market cap near $219B, double-digit free cash flow and defensive demand, PEP is an actionable long with defined risk controls. The trade below targets upside toward the prior 52-week high while keeping a tight stop…
PepsiCo's pricing power, durable cash flow and an improving cost/mix backdrop support a tactical upgrade to long. The stock trades near $160 with a 3.5% yield, EV/EBITDA of 15.5 and FCF of $7.7B — valuations that leave room for upside as operating momentum normalizes. Trade plan provided for a mid-term swing (45 trading days).
LifeMD is cheaply priced for a telehealth platform that now offers GLP-1s (Wegovy/Ozempic) at competitive cash-pay rates, has positive free cash flow, and an enterprise value under $170M. With current technical momentum, a rising short interest profile, and clear distribution catalysts, a disciplined long with a $3.25 stop and $7.50 target offers a…
Hudson Technologies looks like an asymmetric opportunity: industrial cash-flow business, recent tuck-ins that expand recovered refrigerant supply, and valuation metrics (EV/EBITDA ~4.85, P/FCF ~5.58) that price in weakness. Technicals are oversold, creating a measured swing trade with a clear stop and a realistic target near prior highs.
Upstart is trading near its 52-week low despite improving technicals, a low RSI, and the prospect that a bank charter or similar deposit access could materially cut funding costs and lift margins. With a $2.67B market cap, negative free cash flow, and ongoing legal noise, this is a high-risk, high-reward swing trade: entry $27.00, stop $24.00, targ…
Solstice Advanced Materials is a speculative way to capture the 8.5% CAGR in advanced composites through 2033. Industry demand from aerospace and EVs is a clear tailwind; absent up-to-date market-cap or recent filings, this is a tactical, mid-term long aimed at event-driven upside and improving margin narratives. Entry $6.50, stop $4.90, target $9.…
TJX's off-price model has continued to prove defensive and profitable: strong margins, high ROE, low leverage, and $4.4B of free cash flow underpin a mid-term long trade. Technicals show a neutral base near the 20-day moving average; I'll take a long swing with a defined entry at $157.50, a $170 target, and a $150 stop over ~45 trading days.
LandBridge controls contiguous Permian acreage with low operating costs and strong per-well returns. This trade targets a capital-efficient re-rating driven by production infill, takeaway improvements and disciplined capital allocation. Enter at $6.50, stop $5.00, target $10.00 over a long-term (180 trading days) horizon.
Oracle rallied after a clean Q3 beat and raised guidance, driven by 44% cloud growth, 84% infrastructure growth and a $553 billion backlog. The market is worried about heavy CapEx and negative free cash flow, but the worst of the spending fear may already be priced in. We outline a mid-term swing trade with explicit entry, stop and target while fla…
Kratos (KTOS) is a high-growth, government-facing unmanned systems and mission solutions company with recent contract wins, an expanded balance sheet via a $1.17B equity raise, and a pipeline into large programs like SHIELD. Valuation is rich but the company has low leverage, meaningful cash and a clear path to revenue growth. This trade idea lays …
Oracle's Q3 beats and a huge AI-driven backlog justify a tactical long. Strong cloud and infrastructure growth (OCI +84% in infra) and raised guidance to $90B create a path to meaningful multiple expansion, but heavy CapEx, negative free cash flow and large debt require a disciplined stop. We lay out an entry, target and stop for a mid-term (45 tra…
Oracle reported another quarter of robust cloud growth and a jaw-dropping $553 billion in remaining performance obligations, keeping the core growth story intact. The market has punished the name for heavy AI infrastructure spending and short-term cash-flow stress. This trade idea buys the dislocation: enter near $164.00, stop at $142.00, target $2…
Novo Nordisk traded near the low end of its range after a difficult 2025. The recent Hims & Hers agreement and resolution of litigation removes an uncertainty and creates a modest new distribution channel for Wegovy/Ozempic. At a market cap of roughly $172.4B and a P/E near 11, the stock offers asymmetric upside over the next 45 trading days if mom…
Kinsale's specialty underwriting economics and cash generation justify a buy here. The stock trades at a reasonable P/E with strong ROE and sizeable free cash flow, presenting a favorable risk/reward for a mid-term swing trade.
Royal Caribbean Group (RCL) is trading below momentum averages after a recent oil-driven selloff in travel names. With fuel tailwinds, record 2025 results, a 50% dividend increase and a sub-$100B enterprise value, the risk/reward favors a long trade targeting the consensus outlook near $350 over the next 6 months while using a clear stop to limit d…
Intuitive Surgical remains the leader in robotic-assisted surgery with strong recurring revenue from instruments and a growing installed base. Fundamental strength and long-term opportunity are intact, but a rich valuation (P/E ~61, market cap ~$172B) and rising competition argue for a Hold. For traders, consider a disciplined buy-on-weakness plan …
Nu Holdings ($NU) recently pulled back after a strong 2025 showing. With 45% revenue growth, reported customer counts above 100M, and a market cap near $70.2B, the company sits at an attractive risk/reward if credit performance and U.S. expansion clarity hold. This trade idea lays out a mid-term long with clear entry, target and stop.
Taiwan Semiconductor Manufacturing (TSM) dipped from recent highs as momentum cooled and short-volume ticked up. Fundamentals tied to the AI data-center buildout remain intact: TSMC controls the advanced foundry moat, reported strong 2025 revenue and EPS growth, and stands to benefit from hyperscaler capex. This trade plan buys the dip with a mid-t…
Micron has taken center stage in the AI memory race. With recent partnership news, analyst upgrades, and management signaling a robust Q2 ($18.7B revenue, $8.42 EPS), the stock looks set for another leg up into earnings. This is a momentum-driven, event-sensitive trade: enter $410.85, stop $385, target $520 with a short-term horizon (10 trading day…
United Natural Foods (UNFI) is cheap on multiple cash-flow metrics and is starting to show the early signs of margin recovery that the market may be underpricing. With free cash flow of $344M, EV/EBITDA ~10.6 and improving adjusted EPS guidance, a disciplined mid-term long where you buy into momentum and protect capital with a decisive stop makes s…
